Elevation of cytosolic calcium by imidazolines in mouse islets of Langerhans: Implications for stimulus-response coupling of insulin release

British Journal of Pharmacology

Volumn 119, Issue 5, 1996, Pages 911-916

  Shepherd, Ruth M ^a   Hashmi, Molly N ^a   Kane, Charlotte ^a   Squires, Paul E ^a   Dunne, Mark J ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Agmatine; Ca2+; Efaroxan; Fura 2; I receptor; Idazoxan; Imidazoline; K(ATP) channels; Mouse islets; Phentolamine; Tolbutamide

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM); AGMATINE; CALCIUM ION; DIAZOXIDE; EFAROXAN; FURA 2; IDAZOXAN; IMIDAZOLINE DERIVATIVE; IMIDAZOLINE RECEPTOR; INSULIN; PHENTOLAMINE; PHENTOLAMINE MESYLATE;

ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG MECHANISM; INSULIN RELEASE; MICROFLUOROMETRY; MOUSE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL;

EID: 0029859940     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15759.x     Document Type: Article

References (32)

1. AHRÉN, B. & LUNDQUIST, I. (1985). Effects of α-adrenoceptor blockade by phentolamine on basal and stimulated insulin secretion in the mouse. Acta Physiol. Scand., 125, 211-217.
2. ASHCROFT, S.J.H. & ASHCROFT, F.M. (1992). The sulphonylurea receptor. Biochem. Biophys. Acta, 1175, 45-59.
3. ASHCROFT, F.M., HARRISON, D.E. & ASHCROFT, S.J.H. (1984). Glucose induces closure of single potassium channels in isolated rat pancreatic β-cells. Nature, 132, 446-448.
4. 2-adrenoceptor antagonist efaroxan is mediated by a novel, stereoselective, binding site. Eur. J. Pharmacol., 230, 375-378.
5. 2-sites. Br. J. Pharmacol., 112, 1065-1070.
6. 2-adrenergic antagonist, with insulin-secreting cells, Eur. J. Pharmacol., 204, 41-48.
7. CHAN, S.L.F. & MORGAN, N.G. (1990). Stimulation of insulin secretion by efaroxan may involve interaction with potassium channels. Eur. J. Pharmacol., 176, 97-101.
8. DUNNE, M.J. (1991). Block of ATP-regulated potassium channels by phentolamine and other α-adrenoceptor antagonists. Br. J. Pharmacol., 103, 1847-1850.
9. DUNNE, M.J., HARDING, E.A., JAGGAR, J.H., SQUIRES, PE., LIANG, R., KANE, C., LONDON, N.J.M. & JAMES, R.L.F. (1995). Potassium channels, imidazolines and insulin-secreting cells. Ann. New York Acad. Sci. U.S.A., 763, 243-262.
10. DUNNE, M.J. & PETERSEN, O.H. (1991). Potassium selective ion channels in insulin-secreting cells; physiology, pharmacology and their role in stimulus secretion coupling. Biochem. Biophys. Acta (Reviews in Biomembranes), 1071, 67-82.
11. i, and ATP-sensitive potassium currents in insulin-secreting cells. J. Memb. Biol., 114, 54-61.
12. ELLIASSON, L., RENSTRÖM, E ÄMMÄLÄ, C., BERGGREN, P.O., BERTORELLO, A.M., BOKVIST, K., CHIHALIN, A., DEENEY, J.T., FLATT, P.R., GABEL, J., GROMADA, J., LARSSON, O., LINDSTRÖM, P., RHODES, C.J. & RORSMAN, P. (1996). PKC dependent stimulation of exocytosis by sulphonylureas in pancreatic β-cells. Science, 271, 813-815.
13. + channel in pancreatic islet cells can be activated and inactivated by internal calcium. J. Membr. Biol., 83, 169-175.
14. 2+ concentration in an electrically excitable cell, the insulin-secreting pancreatic β-cell. J. Biol. Chem., 267, 20713-20720.
15. 2+ indicators with greatly improved properties. J. Biol. Chem., 260, 3440-3450.
16. HAMILL, O.P., MARTY, A., NEHER, E., SAKMANN, B. & SIGWORTH, F.J. (1981). Improved patch-clamp techniques for high resolution current recordings from cells and cell-free membrane patches. Pflügers Arch., 391, 85-100.
17. + channels in pancreatic β-cells. Br. J. Pharmacol., 107, 8-14.
18. + channels and inhibition of insulin release; effect of BPDZ-62. J. Pharmacol. Exp. Ther., 277, 156-162.
19. LI, G., REGUNATHAN, S., BARROW, C.J., ESHRAGHI, J., COOPER, R. & REIS, D.J. (1994). Agmatine: an endogenous clonidine displacing substance in the brain. Science, 263, 966-969.
20. MICHEL, M.C. & ERNSBERGER, P. (1992). Keeping an eye on the i site: imidazoline-preferring receptors. Trends Pharmacol. Sci., 13, 360-370.
21. MICHEL, M.C. & INSEL, P.A. (1989). Are there multiple imidazoline binding sites? Trends Pharmacol. Sci., 10, 342-344.
22. MORGAN, N.G., CHAN, S.L.F., BROWN, C.A. & TSOLI, E. (1995). Characterization of the imidazoline binding site involved in regulation of insulin secretion. Ann. New York. Acad. Sci. U.S.A., 763, 361-366.
23. 2 receptors. Eur. J. Pharmacol., 262, 41-48.
24. + channels in mouse pancreatic β-cells. Br. J. Pharmacol., 101, 115-120.
25. + channels in pancreatic β-cells. Exp. Clin. Endocrinol., 103, 42-45.
26. SCHULZ, A. & HASSELBLATT, A. (1988). Phentolamine, a deceptive tool to investigate sympathetic nervous control of insulin release. Naunyn-Schmiedeberg's Arch. Pharmacol., 337, 637-643.
27. SCHULZ, A. & HASSELBLATT, A. (1989). An insulin-releasing property of imidazoline derivatives is not limited to compounds that block α-receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 340, 712-714.
28. SENER, A., LEBRUN, P., BLACHIER, F. & MALAISSE, W.J. (1989). Stimulus-secretion coupling of arginine-induced insulin release. Biochem Pharmacol., 38, 327-330.
29. 2+ signals in isolated human insulin-secreting cells. Pflügers Archives, 427, 181-183.
30. 2+ in response to muscarinic and glutamate receptor agonists during the differentiation of NTERA2 human embryonal carcinoma calls into neurones. Eur. J. Neurosci., 8, 783-793.
31. 2+. J. Clin. Invest., 97, 1860-1863.
32. WOLLHEIM, C.B. & SHARP, G.W.G. (1981). The regulation of insulin release by calcium. Physiol. Rev., 61, 914-973.